21076 ⎘
Medicinal preparations containing antigens or antibodies; Protozoa antigens Hemosporidia antigens, e.g. Plasmodium antigens
Pharmaceutical compositions comprising attenuated sporozoites and glycolipid adjuvants
#302Vaccine
#303IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
#304Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#305Methods and Compositions for Preventing a Condition
#306Treatment and prevention of malaria
#307MALARIA VACCINES BASED ON PRE-ERYTHROCYTIC ANTIGENS FROM P. FALCIPARUM
#308Controlled release formulation based on hematin anhydride crystals for the induction of an innate immune reaction
#309Roadmap for controlling malaria
#310Phospholipid drug analogs
#311Consensus antigen constructs and vaccines made therefrom, and methods of using the same to treat malaria
#312Compositions and methods for treatment, research and therapeutic applications for malaria
#313Phospholipid drug analogs
#314Phospholipid drug analogs
#315Antigenic compositions and methods
#316Anti-malaria compositions and methods
#317Vaccine Composition
#318Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression
#319Purified and vaccine composition
#320Purified and vaccine composition
#321Heterologous prime boost vaccination regimen against malaria
#322Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
#323Treatment and prevention of malaria
#324Lentiviral vector based immunological compounds against malaria
#325PLANT-DERIVED CHOLERA AND MALARIA VACCINE
#326MALARIA VACCINE
#327Conjugates of surface proteins as malaria vaccines
#328Vaccines against pregnancy-associated malaria
#329RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEINS 4 AND 5 AND THEIR USE
#330Compositions and methods for immunodominant antigens of
#331Composite body for antigen or drug delivery
#332Synthetic antigen based on the ligand domain of the duffy binding protein
#333ADJUVANT CONTAINING beta-HEMATIN
#334Recombinant baculovirus vaccine
#335ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM
#336Malaria Vaccines
#337Exosomes derived from reticulocytes infected with sp., method for obtaining them and uses thereof
#338Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections
#339Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other C2-domain containing proteins
#340hybrid circumsporozoite protein and vaccine
#341PHARMACEUTICAL COMPOSITIONS COMPRISING ATTENUATED PLASMODIUM SPOROZOITES AND GLYCOLIPID ADJUVANTS
#342STABLE IMMUNOGENIC PROTEIN HAVING MULTIPLE CYSTEINES MOLECULES PROCESS THEREFOR AND COMPOSITION THEREOF
#343Plasmodium falciparum antigens
#344Bacterial spore having therapeutic agent adsorbed on its surface
#345Recombinantly expressed CelTOS antigen and methods of use thereof
#346ENHANCED MALARIA MSP-1 SUBUNIT VACCINE
#347Methods and compositions for treating malaria
#348VIRUS LIKE PARTICLES COMPRISING TARGET PROTEINS FUSED TO PLANT VIRAL COAT PROTEINS
#349Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
#350Transcutaneous immunization without heterologous adjuvant
#351TH1/TH2 polarizing vaccines
#352Nanoparticle Based Immunological Stimulation
#353USE OF TOXOPLASMA AND DERIVED COMPOSITIONS TO PREVENT OR TREAT MICROBIAL INFECTIONS
#354Lipid vesicle compositions and methods of use
#355Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
#356Methods for the Prevention of Malaria
#357Compositions and methods for immunodominant antigens of
#358Non-Integrating Retroviral Vector Vaccines
#359Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction
#360Combined measles-malaria vaccine
#361Recombinant merozoite surface proteins 4 and 5 and their use
#362Production of recombinant proteins in ciliates and uses thereof
#363Drug transporter, and adjuvant and vaccine each utilizing same
#364Recombinant viral-based malaria vaccines
#365METHOD AND COMPOSITION USING A DUAL SPECIFICITY PROTEIN TYROSINE PHOSPHATASE AS AN ANTIMALARIAL DRUG TARGET
#366Immunogenic composition and use thereof
#367Malaria vaccine
#368Purified plasmodium and vaccine compositions
#369Adenovirus vectors
#370Method for treating cancer with vaccine
#371Immunogenic compositions and uses thereof
#372Immunogenic compositions and diagnostic and therapeutic uses thereof
#373MALARIA VACCINE OF SELF-ASSEMBLING POLYPEPTIDE NANOPARTICLES
#374Malaria prime/boost vaccines
#375Phospholipid drug analogs
#376Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
#377MODIFIED CATIONIC LIPOSOME ADJUVANS
#378MALARIA VACCINE BASED ON FRAGMENTS AND COMBINATION OF FRAGMENTS OF THE CS PROTEIN OF PLASMODIUM VIVAX
#379MSP-1 PROTEIN PREPARATIONS FROM PLASMODIUM
#380Compositions and methods for immunodominant antigens of
#381Chimeric MSP-based malaria vaccine
#382VACCINE COMPOSITIONS
#383VACCINE AND IMMUNIZATION METHOD USING PLASMODIUM ANTIGEN 2
#384Vaccines
#385Vaccine compositions comprising a saponin adjuvant
#386METHOD FOR PRODUCING RECOMBINANT VIRUS
#387hybrid circumsporozoite protein and vaccine
#388Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
#389Malaria vaccine
#390METHODS AND REAGENTS FOR VACCINATION WHICH GENERATE A CD8 T CELL IMMUNE RESPONSE
#391Recombinant viral-based malaria vaccines
#392Combined measles-human papilloma vaccine
#393Plasmodium falciparum HLA class I restricted T-cell epitopes
#394Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
#395Plasmodium falciparum sporozoite and liver stage antigens
#396Parasite vaccine
#397Immunogenic Compositions
#398Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
#399Live genetically attenuated malaria vaccine
#400MALARIA VACCINE
#401Self-assembling peptide nanoparticles useful as vaccines
#402METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES
#403Attenuated malaria blood-stage vaccine
#404Recombinant malaria vaccine
#405RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1
#406ADENOVIRAL VECTOR-BASED MALARIA VACCINES
#407Vaccines for malaria
#408Recombinant Adenovirus Vaccines
#409VACCINES FOR MALARIA
#410Plant-Derived Cholera and Malaria Vaccine
#411Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from carrying a Glycosyl-phosphatidyl-inositol group (GPI)
#412Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
#413Recombinant baculovirus vaccine
#414Malaria antigen screening method
#415PLASMODIUM AXENIC LIVER STAGES AS A NONINFECTIOUS WHOLE ORGANISM MALARIA VACCINE
#416vaccines and uses thereof
#417ANTI-MALARIA VACCINE COMPOSITIONS AND USES THEREOF
#418Purified plasmodium and vaccine compositions
#419Conjugates of surface proteins as malaria vaccines
#420LSA-5 liver stage and blood stage antigen of , immunogenic composition comprising said antigen, and vaccines against malaria
#421Recombinant viral-based malaria vaccines
#422Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, AMA1
#423Vaccines for malaria
#424PLASMODIUM FALCIPARUM ANTIGENS INDUCING PROTECTIVE ANTIBODIES
#425Methods and reagents for vaccination which generate a CD8 T cell immune response
#426VACCINE AGAINST MALARIA, BASED ON THE 200L SUBUNITI OF PLASMODIUM VIVAX MSP1 PROTEIN
#427Compositions and methods for immunodominant antigens
#428Use of conditional plasmodium strains lacking an essential gene in malaria vaccination
#429Recombinant merozoite surface proteins 4 and 5 and their use
#430Vaccines for malaria
#431NOVEL METHOD AND COMPOSITIONS
#432Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production
#433Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
#434Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof
#435Recombinant merozoite protein-1vaccine
#436Coiled-coil lipopeptide helical bundles and synthetic virus-like particles
#437METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES
#438Recombinant baculovirus vaccine
#439Methods and reagents for vaccination which generate a CD8 T cell immune response
#440Chloroplast-derived human vaccine antigens against malaria
#441Malaria prime/boost vaccines
#442Compositions and methods for immunodominant antigens of
#443Immunogenic compositions and uses thereof
#444Somatic Transgene Immunization and Related Methods
#445Viral vaccine composition, process and methods of use
#446Compositions comprising chitin microparticles and their medical uses
#447hybrid circumsporozoite protein and vaccine
#448Methods and reagents for vaccination which generate A CD8 T cell immune response
#449mutant with enhanced homologous recombination and uses thereof
#450METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA
#451Adenoviral vector-based malaria vaccines
#452Compositions and methods for treatment, research and therapeutic applications for malaria
#453Chimeric MSP-based malaria vaccine
#454Dry Formulation for Transcutaneous Immunization
#455REPLIKIN PEPTIDES AND USES THEREOF
#456Method for improving the immunogenicity of plasmodium antigens
#457Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction
#458Advanced genetic vaccines
#459Anti-malaria vaccine
#460Recombinant merozoite surface proteins 4 and 5 and their use
#461Vaccine Compositions Comprising a Saponin Adjuvant
#462Disease Prevention and Vaccination Prior to Thymic Reactivation
#463Lyophilization of virosomes
#464High Throughput Proteomics
#465Mycobacteria expressing HIV-1 and malaria antigens
#466ADENOVIRAL VECTOR-BASED MALARIA VACCINES
#467Parasite vaccine
#468Adjuvant systems and vaccines
#469Recombinant viral-based malaria vaccines
#470Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
#471DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
#472Malaria MSP-1 C-terminal enhanced subunit vaccine
#473OIL IN WATER EMULSIONS CONTAINING SAPONINS
#474Hepadna virus core proteins as vaccine platforms and methods of use thereof
#475VACCINES
#476Malaria Prime/Boost Vaccines
#477Vaccines
#478Recombinant merozoite protein-1vaccine
#479Unique DNA and polypeptide sequences based on the circumsporozoite protein of
#480Live genetically attenuated malaria vaccine
#481Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination
#482Methods for conferring immunity against protozoans in an animal
#483Immunogenic compositions comprising Liver Stage Malarial Antigens
#484Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays
#485Somatic transgene immunization and related methods
#486Vaccines for blocking transmission of
#487Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP
#488Recombinant viral-based malaria vaccines
#489Recombinant viral-based malaria vaccines
#490Compositions and methods for inactivating or suppressing inflammatory cells
#491Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
#492Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
#493Method of preparing polyepitope chimeric gene vaccine
#494Live genetically attenuated malaria vaccine
#495Vaccine Composition Against Malaria
#496Plasmodium falciparum AMA-1 protein and uses thereof
#497Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
#498Vaccines
#499antigens inducing protective antibodies
#500Methods for vaccinating against malaria
#501Peptide sequences specific for the hepatic stages of bearing epitopes capable of stimulating the T lymphocytes
#502Immunogenic compositions and diagnostic and therapeutic uses thereof
#503Regulated bacterial lysis for gene vaccine vector delivery and antigen release
#504Peptide constructs for treating disease
#505Recombinant mva strains as potential vaccines against p. falciparum malaria
#506Live genetically engineered protozoan vaccine
#507Expression, purification and uses of a liver stage antigen 1 polypeptide
#508Vaccine composition against malaria
#509Induction of cytotoxic T-lymphocyte responses
#510Antigen library immunization
#511Malaria vaccine
#512Recombinant protein containing a C-terminal fragment of MSP-1
#513Transcutaneous immunization without heterologous adjuvant
#514Malarial pre-erythrocytic stage polypeptide molecules
#515antigens inducing protective antibodies
#516Recombinant viral-based malaria vaccines
#517Pulmonary malarial vaccine
#518Carboxypeptidases B from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
#519Universal T-cell epitopes for anti-malarial vaccines
#520Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccine
#521Live genetically attenuated malaria vaccine
#522Methods for the prevention of malaria
#523Vaccines containing a saponin and a sterol
#524Methods for the prevention of malaria
#525Malaria immunogen and vaccine
#526Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines
#527Replikin peptides and uses thereof
#528Method and composition
#529Baculovirus produced vaccine
#530Human hepatoma lines, methods for obtaining same and uses thereof
#531polypeptides and methods of using same
#532Methods and compositions for inducing immune responses and protective immunity by priming with alpha virus replicon vaccines
#533Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
#534Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
#535Vaccine
#536Vaccines
#537Synthetic plasmodium antigens, compositions, and uses thereof
#538TAA/CD4OL composition/vaccine for malaria
#539Synthetic antigen based on the ligand domain of the plasmodium vivax duffy binding protein
#540TAA/CD40L vaccine for malaria
#541Simian adenoviral vectors encoding malaria antigen